|
Omeros Accused on Eve of IPO, Seattle Genetics Trial Fails, How Much Biotechies Really Earn, & More Seattle-Area Life Sciences News.(Business)
Seattle Post-Intelligencer (Seattle, WA)
|
October 8, 2009
|
COPYRIGHT 2009 Seattle Post-Intelligencer. All rights reserved. Reproduced with the permission of Dialog LLC by Gale Group. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group.
(Hide copyright information)
Copyright
|
Omeros is attempting to become the first true biotech company to go public in more than a year, and the first in Washington state in two years, but it will have to overcome controversy to do it.
Xconomy Seattle About Xconomy
Headlines from Xconomy
PATH Wins $1.5M Hilton Prize, World's Biggest Award for Humanitarian Work
Apptio Raises $14M to Expand, "Crush the Competition" in IT Financial Management
Xconomy Goes Mobile at m.xconomy.com
-Seattle-based Omeros, the biotech company with a treatment to help patients recover ...
|
Novel PCR assay useful for rapid detection of emetic Bacillus cereus.
Newspaper article from: Genomics & Genetics Weekly
; ...assay is useful for the rapid detection of emetic Bacillus cereus. According to recent...Bacillus cereus strains able to produce an emetic toxin (cereulide) was developed in this...tested. Results were positive for every emetic B. cereus strain and for only one nonemetic...
|
|
Prophylaxis of postoperative nausea and vomiting: Gabapentin a new anti-emetic approach?
Magazine article from: Journal of Postgraduate Medicine
; ...colleagues showed that various anti-emetic strategies are associated with a very...25-30%.[1] All evaluated anti-emetic approaches (dexamethasone, droperidol...gabapentin and other established anti-emetic interventions. The present study raises...
|
|
PRESCRIPTION GI DRUGS TO TOP $6 BILLION BY 2000, LED BY GENERICS, ANTI-EMETICS.
Business Wire
; ...BUSINESS EDITORS)--Paced by anti-emetics and constrained in revenue terms by rapid...released by Frost & Sullivan. Anti-emetics, primarily to ease nausea and vomiting...nausea and vomiting, supporting the anti-emetic market. H2-antagonist drugs, which...
|
|
Natco signs LoI with Akorn for anti-emetic cancer drugs.
News Wire article from: PTI - The Press Trust of India Ltd.
; Natco signs LoI with Akorn for anti-emetic cancer drugs New Delhi, Dec 20 (PTI) To enter the US and European...and Natco. The two ANDAs drug product will focus on the anti-emetic market and have a current market size of approximately 800 million...
|
|
Tasly Diyi gets EU certificate for anti-emetic pharmaceutical ingredient.
Newspaper article from: China Business News
; Tasly Diyi gets EU certificate for anti-emetic pharmaceutical ingredient Shanghai. July 19. INTERFAX-CHINA...Sulpiride is active pharmaceutical ingredient with anti-emetic function, which works by inhibiting the secretion of gastric...
|
|
NovaDel Initiates Pilot Clinical Study of Lingual Spray Version of World's Leading Anti-Emetic.
Business Wire
; ...spray formulation of ondansetron, the largest selling anti-emetic agent, currently marketed in the US as Zofran (R) by GlaxoSmithKline...2004, and the majority of these patients received an anti-emetic such as ondansetron to prevent nausea and vomiting. NovaDel...
|
|
Anti-emetics in early pregnancy.(THE BEST OF THE REST)(Brief article)
Magazine article from: South African Journal of Obstetrics and Gynaecology
; Metoclopramide is the anti-emetic of choice in early pregnancy in many European countries. In the USA it is used in severe cases, but it is not 'labelled' for...
|
|
Woodside Biomedical Receives FDA Clearance to Market ReliefBand Device to Reduce Post-Operative Nausea as an Adjunct to Anti-Emetics.
Business Wire
; ...reducing post-operative nausea when used as an adjunct to anti-emetics, announced Greg Gruzdowich, Woodside's president and chief...operative environment. "Many of the commonly used anti-emetic drugs work very well for treating post-operative vomiting...
|
|
Non-pharmacologic cause of anti-emetic resistant postoperative nausea and vomiting
Magazine article from: Anaesthesia and Intensive Care
; ...reflex and subsequent retching. After having been discovered in this activity her PONV and requests for additional anti-emetics ceased. This may be the first recorded case where self -induced vomiting was a feature in the postoperative period. [Author...
|
|
INDIA'S NATCO SIGNS LoI WITH AKORN FOR ANT-EMETIC CANCER DRUGS.
News Wire article from: AsiaPulse News
; ...90 days "upon terms and conditions agreeable" to both Akorn and Natco. The two ANDAs drug product will focus on the anti-emetic market and have a current market size of approximately US$800 million, it said. While Natco will develop and manufacture...
|
Find more facts and information related to the
article "Omeros Accused on Eve of IPO, Seattle Genetics ..."